Cyclodextrin Drug Trial Update November 14, 2012 From Dr. Forbes Porter, Clinical Director of the Division of Intramural Research at the National Institute of Child Health and Human Development, National Institutes of Health in Bethesda, Maryland. The Therapies for Rare and Neglected Diseases (TRND) team is pleased to announce that the Investigational New Drug (IND) …
Category
Showing: 37 - 39 of 46 RESULTS
Niemann-Pick Type C News
DART to fund summer internships for 2012
For the second summer, DART will be sponsoring four undergraduate science students to work in research laboratories studying Niemann-Pick type C disease. Each of the labs is involved on the front lines of developing therapies for NP-C and two are working on obtaining approval from the U.S. Food and Drug Administration for a new drug …